Table 3 Influence of six factors on recurrence-free survival in a Cox multivariable model in the SSGXVIII/AIO series
From: SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
Variable | Hazard ratio (95% CI) | P |
|---|---|---|
Tumour mitotic count | 1.03 (1.02–1.03) | <0.001 |
As a continuous variable | ||
Tumour site | 3.03 (2.05–4.46) | <0.001 |
Non-gastric vs gastric | ||
Duration of adjuvant imatinib | 2.22 (1.52–3.22) | <0.001 |
1 year vs 3 years | ||
Tumour rupture | 2.25 (1.52–3.33) | <0.001 |
Present vs absent | ||
Tumour size | 1.05 (1.02–1.07) | 0.001 |
As a continuous variable | ||
Tumour SLUG expression | 1.63 (1.13–2.36) | 0.009 |
Present vs absent |
